These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6882623)

  • 21. The pharmacokinetics of cyclophosphamide in man following treatment with methotrexate.
    Mouridsen HT; Jacobsen E; Faber O
    Acta Pharmacol Toxicol (Copenh); 1976 May; 38(5):508-12. PubMed ID: 989253
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of (+/-)-, (+)-, and (-)-gossypol in humans and dogs.
    Wu DF; Yu YW; Tang ZM; Wang MZ
    Clin Pharmacol Ther; 1986 Jun; 39(6):613-8. PubMed ID: 3709025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of experimentally induced cholestasis on the pharmacokinetics of cefotiam.
    Alonso IG; Mariño EL; Dominguez-Gil A
    Arzneimittelforschung; 1984; 34(7):798-800. PubMed ID: 6093824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance lithium levels could be lowered: based on Taiwanese and Danish studies.
    Yang YY; Yeh EK; Chang SS; Deng HC; Lee CF
    J Formos Med Assoc; 1991 May; 90(5):509-13. PubMed ID: 1680992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man.
    Faber OK; Mouridsen HT; Skovsted L
    Br J Clin Pharmacol; 1975 Jun; 2(3):281-5. PubMed ID: 791322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of damaged liver parenchyma, renal insufficiency and hemodialysis on the pharmacokinetics of cyclophosphamide and its activated metabolites].
    Wagner T; Heydrich D; Bartels H; Hohorst HJ
    Arzneimittelforschung; 1980; 30(9):1588-92. PubMed ID: 7193030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of the cytostatic drugs used in the CMF-regimen.
    Slee PH; de Bruijn EA; Driessen OM; Hermans J; van Oosterom AT
    Anticancer Res; 1983; 3(4):269-71. PubMed ID: 6688337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
    Hong PS; Srigritsanapol A; Chan KK
    Drug Metab Dispos; 1991; 19(1):1-7. PubMed ID: 1673381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis and pharmacokinetics of cimaterol in growing Holstein steers.
    Byrem TM; Robinson TF; Boisclair YR; Bell AW; Schwark WS; Beermann DH
    J Anim Sci; 1992 Dec; 70(12):3812-9. PubMed ID: 1361928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of dothiepin. Single-dose kinetics in patients and prediction of steady-state concentrations.
    Maguire KP; Norman TR; McIntyre I; Burrows GD
    Clin Pharmacokinet; 1983; 8(2):179-85. PubMed ID: 6851370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.
    Flouvat BL; Imbert C; Dubois DM; Temperville BP; Roux AF; Chevalier GC; Humbert G
    Br J Clin Pharmacol; 1983 Jun; 15(6):735-41. PubMed ID: 6871072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of crystalloid fluid changes with the rate of infusion: a population-based study.
    Hahn RG; Drobin D; Zdolsek J
    Acta Anaesthesiol Scand; 2016 May; 60(5):569-78. PubMed ID: 26763732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of nitrofurantoin in the bodies of pregnant rats].
    Wierzba K; Wańkowicz B; Prokopczyk J; Piekarczyk A
    Probl Med Wieku Rozwoj; 1984; 13():185-92. PubMed ID: 6531347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of amiodarone after intravenous and oral administration.
    Anastasiou-Nana M; Levis GM; Moulopoulos S
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):524-9. PubMed ID: 7174155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of potassium ampicillin.
    Kaumeier S; Kisslinger E; Neiss A
    Arzneimittelforschung; 1980; 30(6):1019-21. PubMed ID: 7191262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased half life of cyclophosphamide in patients under continual treatment.
    D'Incalci M; Bolis G; Facchinetti T; Mangioni C; Morasca L; Morazzoni P; Salmona M
    Eur J Cancer (1965); 1979 Jan; 15(1):7-10. PubMed ID: 421718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.